Even as researchers try to find biomarkers to predict ketamine reaction, clinicians come across on their own with a conundrum: Which patients must start with IV ketamine, and which with Spravato? And exactly how do The 2 compare head to head in real response to treatment? examined using IV ketamine https://silasb233wly2.wikissl.com/user